Integrated safety summary for trifluridine/tipiracil (TAS-102)
2018
Trifluridine/tipiracil, an oral treatment combining trifluridine (an antineoplastic thymidine-based nucleoside analog) and tipiracil hydrochloride (a thymidine phosphorylase inhibitor), led to significant improvement in overall survival in metastatic colorectal cancer (mCRC) patients refractory to s
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
13
References
8
Citations
NaN
KQI